RIL
BBNX

Rothschild Investment LLC’s Beta Bionics BBNX Stock Holding History

Rothschild Investment LLC’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$90 Sell
9
-8
-47% -$118 ﹤0.01% 3410
2025
Q4 		$518 Buy
17
+12
+240% +$320 ﹤0.01% 2915
2025
Q3 		$99 Buy
+5
New +$88 ﹤0.01% 3067

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Rothschild Investment LLC's BBNX Position: Q1 2026 in Review

Rothschild Investment LLC reduced its Beta Bionics (BBNX) stake by 47% in Q1 2026, selling an estimated $118 and leaving 9 shares worth $90. The position accounts for ﹤0.01% of the portfolio, ranked #3410.

Rothschild Investment LLC first reported a position in BBNX in Q3 2025 and has held it in 3 quarters since. The position peaked at $518 in Q4 2025. 130 funds tracked by Wall St. Rank hold BBNX as of Q1 2026.

  • Rothschild Investment LLC held 9 shares of Beta Bionics worth $90 as of Q1 2026.
  • Rothschild Investment LLC sold 8 Beta Bionics shares in Q1 2026, an estimated $118.
  • Beta Bionics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q1 2026, its #3410 holding.
  • Rothschild Investment LLC first reported a position in Beta Bionics in Q3 2025 and has held it in 3 quarters since.
  • Rothschild Investment LLC's Beta Bionics position peaked at $518 in Q4 2025.
  • 130 funds tracked by Wall St. Rank held Beta Bionics as of Q1 2026.

Based on Rothschild Investment LLC's 13F filing for Q1 2026, filed 7 May 2026.